High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality

Documents similaires

• Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation
  par: Moazzam Shahzad, et autres
  Publié: (2024)
• Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab
  par: Junjie Cao, et autres
  Publié: (2024)
• Prediction of CD34+ hematopoietic stem cells in healthy allogeneic stem cell donors on the Optia cell separator based on CE2: Which formula is more correlated with actual CD34+?
  par: Sıdıka Gülkan Özkan, et autres
  Publié: (2024)
• Impact of plerixafor use in the mobilization of blood grafts for autologous hematopoietic cell transplantation
  par: Esa Jantunen, et autres
  Publié: (2024)
• Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non‐relapse mortality in acute myeloid leukemia patients
  par: Shan Yuan, et autres
  Publié: (2024)